"Our second quarter performance reflects the consistency of our execution and the strength of the operating platform we’ve ...

The Oncology Institute, Inc. (NASDAQ: TOI) ('TOI” or the 'Company”), one of the largest value-based community oncology groups ...

Epsilon Energy Ltd. ('Epsilon” or the 'Company”) (NASDAQ: EPSN) today announced it has entered into definitive agreements to ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

The Oncology Institute, Inc. ("TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, ...

DLocal Limited ('dLocal”, 'we”, 'us”, and 'our”) (NASDAQ:DLO), a technology - first payments platform, today announced the ...

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based ...

Conifer Holdings, Inc. (Nasdaq: CNFR) ('Conifer” or the 'Company”) today announced results for the second quarter ended June ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging ...

Robinhood Markets, Inc. ('Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for July 2025.

Hyperion DeFi, Inc. (NASDAQ: HYPD), the first publicly-listed U.S. company to implement DeFi strategies on its treasury of HYPE, the native token of the Hyperliquid protocol, and a pioneer in ...

Company now plans to share updated OS and PFS data from first-line pancreatic cancer patients (N = 34) treated with atebimetinib + mGnP in Q3 2025, earlier than prior guidance - ...